Infinity
Device Neuromodulation
PDI 05415067020277
General payments
$1,659,914
Research payments
$3,487,524
Through program year 2025, $1,659,914 in general payments and $3,487,524 in research payments were reported against Infinity (Neuromodulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,832 | 27 |
| 2025 | Research | $2,252,261 | 579 |
| 2024 | General | $634,276 | 4,788 |
| 2024 | Research | $339,022 | 196 |
| 2023 | General | $531,479 | 5,236 |
| 2023 | Research | $401,979 | 171 |
| 2022 | General | $492,328 | 4,141 |
| 2022 | Research | $494,262 | 306 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
14,192 general · 1,252 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.